532488 · Divi's Laboratories Limited
9040.00
INRUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
INR2.40T
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Payout Ratio
32%
MQV Rating
1Very Strong
As at 15/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- HALO 200
- HALO All
- HALO Earnings Momentum
- HALO Momentum
- HALO MQV
- HALO MQV SMALL
- HALO Small
- Recent Price upgrade
Key Fundamentals
EPS 3 yr Growth
60.50%
EBITDA Margin
32.60%
Operating Cashflow
₹27,705m
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
149.60
Quick Ratio
N/A
Performance
52 weeks range
Low 5648 - 10000
Trade Value (12mth)
US$455,119.00
1 week
-3.72%
1 month
-1.74%
YTD
42.53%
1 year
47.43%
All time high
10000.00
Additional Data
Shares Outstanding (Fully Diluted)
265m
HALO Sector
Healthcare
Next Company Report Date
24-May-27
Next Ex Dividend Date
24-Jul-26
Next Dividend Pay Date
14-Aug-26
Reporting Currency
INR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Strong
Garp
Neutral
Mqv Small
Very Strong
Momentum
Price
Neutral
Earnings
Very Strong
Growth
Earnings
Strong
Dividends
Weak
Quality
Capital Efficiency
Strong
Balance Sheet
Strong
Valuation
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Nilima Prasad Divi | Individual |
| Satchandra Kiran Divi | Individual |
| Swarna Latha Divi | Individual |
| Divis Biotech Pvt Ltd. | Private Company |
| Murali Krishna P. Divi | Individual |